drugset / Trial / NCT02608710
RDEA3170 PK/PD Study
RandomizedParallel-groupOpen-labelBasic science
Summary
The purpose of this study is to examine the pharmacokinetic and pharmacodynamic effect of RDEA3170 when given as single or multiple doses
Timeline
- Start
- 2015-11
- Primary completion
- 2015-12
- Completion
- 2016-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Verinurad | Small molecule | 4.5 mg | — |
| Subject | Verinurad | Small molecule | 6 mg | — |
| Subject | Verinurad | Small molecule | 12 mg | — |